X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (486) 486
index medicus (440) 440
ophthalmology (309) 309
male (299) 299
conjunctival neoplasms - drug therapy (287) 287
female (268) 268
conjunctival neoplasms - pathology (223) 223
aged (220) 220
middle aged (215) 215
adult (175) 175
treatment outcome (126) 126
administration, topical (114) 114
carcinoma in situ - drug therapy (101) 101
aged, 80 and over (93) 93
eye neoplasms - drug therapy (85) 85
antineoplastic agents - therapeutic use (81) 81
corneal diseases - drug therapy (80) 80
tumors (76) 76
carcinoma, squamous cell - drug therapy (75) 75
conjunctiva (75) 75
conjunctival neoplasms - surgery (72) 72
follow-up studies (72) 72
mitomycin - therapeutic use (69) 69
chemotherapy (66) 66
mitomycin - administration & dosage (65) 65
antibiotics, antineoplastic - therapeutic use (61) 61
carcinoma in situ - pathology (60) 60
interferon-alpha - therapeutic use (59) 59
ophthalmic solutions (58) 58
biopsy (57) 57
carcinoma, squamous cell - pathology (57) 57
retrospective studies (57) 57
conjunctival neoplasms - diagnosis (56) 56
melanoma (55) 55
abridged index medicus (54) 54
cancer (53) 53
melanoma - drug therapy (52) 52
antineoplastic agents - administration & dosage (51) 51
corneal diseases - pathology (49) 49
interferon-alpha - administration & dosage (49) 49
recombinant proteins (49) 49
care and treatment (48) 48
eye neoplasms - pathology (48) 48
therapy (47) 47
antibiotics, antineoplastic - administration & dosage (44) 44
combined modality therapy (44) 44
antineoplastic combined chemotherapy protocols - therapeutic use (41) 41
melanoma - pathology (41) 41
squamous cell carcinoma (41) 41
surgery (41) 41
conjunctival neoplasms - therapy (40) 40
corneal intraepithelial neoplasia (40) 40
diagnosis, differential (40) 40
diagnosis (37) 37
management (37) 37
lymphoma, b-cell, marginal zone - drug therapy (36) 36
medicine & public health (36) 36
mitomycin (36) 36
mitomycin-c (36) 36
conjunctival (35) 35
neoplasm recurrence, local - drug therapy (35) 35
oncology (35) 35
5-fluorouracil (34) 34
conjunctival melanoma (34) 34
drug therapy (33) 33
interferon (33) 33
prospective studies (33) 33
conjunctiva - pathology (32) 32
conjunctival intraepithelial neoplasia (32) 32
mitomycin - adverse effects (32) 32
mitomycin c (32) 32
carcinoma, squamous cell - surgery (31) 31
primary acquired melanosis (31) 31
cell carcinoma (28) 28
chemotherapy, adjuvant (28) 28
cryotherapy (28) 28
lymphoma, b-cell, marginal zone - pathology (28) 28
lymphomas (28) 28
malignant-melanoma (28) 28
neoplasia (28) 28
prognosis (28) 28
eye diseases (27) 27
eyelid neoplasms - drug therapy (26) 26
ocular surface squamous neoplasia (26) 26
radiotherapy (26) 26
corneal (25) 25
antibiotics, antineoplastic - adverse effects (24) 24
conjunctival neoplasms - etiology (24) 24
cornea (24) 24
adolescent (23) 23
carcinoma in situ - surgery (23) 23
child (23) 23
epithelial dysplasia (23) 23
neoplasm recurrence, local (23) 23
patients (23) 23
antineoplastic agents - adverse effects (22) 22
conjunctival lymphoma (22) 22
experience (22) 22
eye (22) 22
eye neoplasms - surgery (22) 22
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (479) 479
German (21) 21
Spanish (16) 16
French (4) 4
Polish (4) 4
Portuguese (4) 4
Japanese (3) 3
Chinese (1) 1
Danish (1) 1
Italian (1) 1
Norwegian (1) 1
Romanian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 5, pp. 994 - 1000
Purpose Treatment for ocular surface squamous neoplasia (OSSN) has historically been surgery, but nonsurgical interventions are increasingly used. Treatment... 
AMERICAN-JOINT-COMMITTEE | CORNEAL | SOLID TUMORS | MITOMYCIN-C | OPHTHALMOLOGY | TERM-FOLLOW-UP | CANCER-CLASSIFICATION | CONJUNCTIVAL INTRAEPITHELIAL NEOPLASIA | HUMAN-PAPILLOMAVIRUS | TOPICAL INTERFERON-ALPHA-2B | CELL CARCINOMA | Recombinant Proteins - therapeutic use | Corneal Diseases - therapy | Conjunctival Neoplasms - drug therapy | Conjunctival Neoplasms - surgery | Carcinoma in Situ - drug therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Squamous Cell - surgery | Male | Antineoplastic Agents - therapeutic use | Eye Neoplasms - therapy | Eye Neoplasms - surgery | Case-Control Studies | Ophthalmologic Surgical Procedures | Eye Neoplasms - drug therapy | Carcinoma in Situ - surgery | Aged, 80 and over | Ophthalmic Solutions | Adult | Female | Corneal Diseases - pathology | Postoperative Complications | Visual Acuity - physiology | Carcinoma in Situ - pathology | Risk Factors | Eye Neoplasms - pathology | Interferon-alpha - therapeutic use | Carcinoma, Squamous Cell - therapy | Corneal Diseases - drug therapy | Treatment Outcome | Neoplasm Recurrence, Local - diagnosis | Carcinoma in Situ - therapy | Conjunctival Neoplasms - therapy | Conjunctival Neoplasms - pathology | Corneal Diseases - surgery | Carcinoma, Squamous Cell - drug therapy | Aged | Neoplasm Staging | Cryotherapy | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3, pp. e0118564 - e0118564
Journal Article
Ophthalmology, ISSN 0161-6420, 2008, Volume 115, Issue 8, pp. 1297 - 1302.e1
Journal Article
Cancer Science, ISSN 1347-9032, 11/2011, Volume 102, Issue 11, pp. 1972 - 1976
We evaluated the association between tumor‐infiltrating FOXP3+ T cells and clinical outcomes in patients with ocular adnexal lymphoma of mucosa‐associated... 
HODGKINS LYMPHOMA | B-CELLS | SURVIVAL | HIGH NUMBERS | CHLAMYDIA-PSITTACI | ONCOLOGY | MARGINAL ZONE | REGULATORY T-CELLS | SJOGRENS-SYNDROME | FOLLICULAR LYMPHOMA | MALT LYMPHOMA | Lacrimal Apparatus Diseases - immunology | Conjunctival Neoplasms - drug therapy | Lymphoma, B-Cell, Marginal Zone - radiotherapy | Prognosis | Humans | Middle Aged | Eyelid Neoplasms - immunology | Male | Eye Neoplasms - immunology | Conjunctival Neoplasms - immunology | Antigens, CD - analysis | Antigens, Differentiation, T-Lymphocyte - analysis | Eye Neoplasms - drug therapy | Eyelid Neoplasms - radiotherapy | Lacrimal Apparatus Diseases - drug therapy | Female | Lymphocytes, Tumor-Infiltrating - chemistry | Lymphoma, B-Cell, Marginal Zone - pathology | Conjunctival Neoplasms - radiotherapy | Neoplasm Proteins - genetics | Republic of Korea - epidemiology | Orbital Neoplasms - radiotherapy | Caspases - genetics | Doxycycline - therapeutic use | Eye Neoplasms - pathology | Eyelid Neoplasms - drug therapy | Kaplan-Meier Estimate | Orbital Neoplasms - pathology | Lymphoma, B-Cell, Marginal Zone - immunology | Immunophenotyping | Orbital Neoplasms - drug therapy | Treatment Outcome | Eyelid Neoplasms - pathology | Conjunctival Neoplasms - pathology | Remission Induction | Lacrimal Apparatus Diseases - radiotherapy | Disease-Free Survival | Orbital Neoplasms - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell, Marginal Zone - drug therapy | Forkhead Transcription Factors - analysis | Watchful Waiting | Aged | Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | Lacrimal Apparatus Diseases - pathology | Eye Neoplasms - radiotherapy | Lymphocytes, Tumor-Infiltrating - immunology | Evaluation | Care and treatment | Chemotherapy | Image processing | Oncology, Experimental | Monoclonal antibodies | Lymphomas | Equipment and supplies | Research | Drug therapy, Combination | T cells | Cancer | Index Medicus
Journal Article
Cornea, ISSN 0277-3740, 03/2013, Volume 32, Issue 3, pp. 248 - 256
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 77, Issue 1, pp. 86 - 91
Purpose To evaluate the outcomes of patients with localized orbital marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma) who... 
Radiology | Hematology, Oncology and Palliative Medicine | Orbit | Marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) | Radiotherapy (RT) | AREA | ONCOLOGY | CATARACTS | OCULAR ADNEXA | CLASSIFICATION | CLINICAL BEHAVIOR | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Conjunctival Neoplasms - drug therapy | Cyclophosphamide - administration & dosage | Lymphoma, B-Cell, Marginal Zone - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Young Adult | Eyelid Neoplasms - radiotherapy | Vincristine - administration & dosage | Adult | Female | Conjunctival Neoplasms - radiotherapy | Retrospective Studies | Orbital Neoplasms - radiotherapy | Doxorubicin - administration & dosage | Radiotherapy Dosage | Prednisone - administration & dosage | Cataract - etiology | Eyelid Neoplasms - drug therapy | Treatment Outcome | Radiation Injuries - complications | Remission Induction | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell, Marginal Zone - drug therapy | Aged | Retreatment - methods | Lacrimal Duct Obstruction - etiology | Salvage Therapy - methods | Index Medicus | NEOPLASMS | IMMUNE SYSTEM DISEASES | MEMBRANES | RADIATION DOSES | MEDICINE | NUCLEAR MEDICINE | LYMPHOMAS | DISEASES | THERAPY | DOSES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOLOGY | MUCOUS MEMBRANES
Journal Article
Journal Article
Journal Article